Cohen N L, Keen C L, Lönnerdal B, Hurley L S
J Nutr. 1985 May;115(5):633-49. doi: 10.1093/jn/115.5.633.
The effect of dietary iron on the development of copper-deficiency anemia in the growing rat was investigated. For up to 80 d, female rats (75 g) were fed purified diets containing adequate, marginal or low levels of iron, and either 0.7 or 10 ppm copper. Hemoglobin levels and factors postulated to affect liver iron mobilization, including ferroxidase (Fox) I and II, ascorbate and liver xanthine dehydrogenase (XDH) were assayed. By d 7, Fox I activity in the copper-deficient groups was 10% that of the copper-sufficient groups; thereafter, Fox I activity remained low, and was not affected by dietary iron. Fox II activity in the copper-deficient groups after d 28 was 50-75% of values from rats adequate in copper. On d 49, hemoglobin levels in the copper-deficient groups were lower than in the copper-sufficient groups fed low and marginal levels of iron, but were similar to those fed adequate iron. Liver iron was similar in both groups fed adequate iron, but was higher in the copper-deficient than in the copper-sufficient rats fed low or marginal levels of iron. Copper deficiency tended to result in slightly lower ascorbate levels on d 80 at all levels of iron. Liver XDH activity tended to be lower in the copper-deficient groups than in the copper-sufficient groups on d 28 and 49. These results show that copper deficiency may impair liver iron mobilization in the growing rat if dietary iron is low. Possible mechanisms include decreased Fox activity and/or decreased iron reduction by ascorbate or XDH.
研究了日粮铁对生长中大鼠铜缺乏性贫血发展的影响。雌性大鼠(75克)连续80天饲喂含有充足、边缘或低水平铁以及0.7或10 ppm铜的纯化日粮。测定了血红蛋白水平以及假定影响肝脏铁动员的因素,包括铁氧化酶(Fox)I和II、抗坏血酸和肝脏黄嘌呤脱氢酶(XDH)。到第7天时,铜缺乏组的Fox I活性为铜充足组的10%;此后,Fox I活性一直较低,且不受日粮铁的影响。第28天后,铜缺乏组的Fox II活性为铜充足大鼠的50 - 75%。在第49天时,铜缺乏组的血红蛋白水平低于饲喂低水平和边缘水平铁的铜充足组,但与饲喂充足铁的组相似。两组饲喂充足铁时肝脏铁含量相似,但铜缺乏组的肝脏铁含量高于饲喂低水平或边缘水平铁的铜充足大鼠。在第80天时,在所有铁水平下,铜缺乏都倾向于导致抗坏血酸水平略低。在第28天和第49天时,铜缺乏组的肝脏XDH活性倾向于低于铜充足组。这些结果表明,如果日粮铁含量低,铜缺乏可能会损害生长中大鼠的肝脏铁动员。可能的机制包括Fox活性降低和/或抗坏血酸或XDH导致的铁还原减少。